| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1100694519 |
| P356 | DOI | 10.1038/BJC.2017.451 |
| P932 | PMC publication ID | 5846063 |
| P698 | PubMed publication ID | 29381686 |
| P2093 | author name string | Wun-Jae Kim | |
| Jeong Hee Hong | |||
| Christina Jamieson | |||
| Geun Taek Lee | |||
| Isaac Yi Kim | |||
| Young Suk Kwon | |||
| Nara Lee | |||
| Seok Joo Kwon | |||
| Jongmyung Kim | |||
| P2860 | cites work | Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma | Q24300474 |
| The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma | Q24648937 | ||
| Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling | Q28250146 | ||
| WNT signaling in bone homeostasis and disease: from human mutations to treatments | Q28285090 | ||
| Low expression of Wnt-5a gene is associated with high-risk neuroblastoma | Q28297914 | ||
| A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities | Q33589161 | ||
| Wnt5a suppresses osteoblastic differentiation of human periodontal ligament stem cell-like cells via Ror2/JNK signaling | Q48168075 | ||
| Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival | Q74153839 | ||
| The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity | Q77678719 | ||
| Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion | Q79322850 | ||
| Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue | Q79358419 | ||
| IL-1β mediates MCP-1 induction by Wnt5a in gastric cancer cells | Q33861443 | ||
| Wnt5a promotes inflammatory responses via nuclear factor κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways in human dental pulp cells | Q33947233 | ||
| Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway | Q34493228 | ||
| RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. | Q34494714 | ||
| Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines | Q34600262 | ||
| Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2 | Q34706774 | ||
| Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability | Q35014686 | ||
| Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines | Q35764436 | ||
| CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration | Q35925135 | ||
| Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation | Q36945973 | ||
| Wnt5a stimulates chemotactic migration and chemokine production in human neutrophils | Q36982055 | ||
| A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score | Q37213040 | ||
| Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases | Q37520844 | ||
| Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters. | Q37618229 | ||
| Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction | Q37650625 | ||
| CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis | Q37652169 | ||
| A novel non-canonical Wnt signature for prostate cancer aggressiveness | Q37706021 | ||
| The dynamic roles of TGF-β in cancer | Q37801347 | ||
| Castration-resistant prostate cancer: adaptive responses in the androgen axis | Q38153927 | ||
| WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo | Q38956252 | ||
| Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway. | Q38981044 | ||
| GEC-derived SFRP5 inhibits Wnt5a-induced macrophage chemotaxis and activation | Q39035083 | ||
| Cancer Statistics, 2017. | Q39038674 | ||
| Bone morphogenetic protein-6 induces castration resistance in prostate cancer cells through tumor infiltrating macrophages | Q39147073 | ||
| ROR-Family Receptor Tyrosine Kinases | Q39150536 | ||
| BMP-6 in renal cell carcinoma promotes tumor proliferation through IL-10-dependent M2 polarization of tumor-associated macrophages | Q39157997 | ||
| Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase | Q39747925 | ||
| Interleukin-6 regulates androgen synthesis in prostate cancer cells | Q39819739 | ||
| WNT5A expression increases during melanoma progression and correlates with outcome | Q39939612 | ||
| Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis | Q40361017 | ||
| WNT5A expression in human breast cancer. | Q40427508 | ||
| The Wnt5a-Ror2 axis promotes the signaling circuit between interleukin-12 and interferon-γ in colitis. | Q41484013 | ||
| Depletion and reconstitution of macrophages in mice | Q42412616 | ||
| WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production | Q42498835 | ||
| Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A. | Q42810068 | ||
| Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice | Q42819394 | ||
| Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway | Q42828494 | ||
| PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche | Q42938836 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2018-01-30 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages |
| Q90062344 | An Autocrine Wnt5a Loop Promotes NF-κB Pathway Activation and Cytokine/Chemokine Secretion in Melanoma |
| Q92603261 | Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis |
| Q100428112 | Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide |
| Q91898018 | Glucocorticoids inhibit macrophage differentiation towards a pro-inflammatory phenotype upon wounding without affecting their migration |
| Q91705838 | Key Genes And Pathways Controlled By E2F1 In Human Castration-Resistant Prostate Cancer Cells |
| Q64103418 | M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22/PI3K/AKT signaling |
| Q92761050 | Phospholipase C (PLC)ε Promotes Androgen Receptor Antagonist Resistance via the Bone Morphogenetic Protein (BMP)-6/SMAD Axis in a Castration-Resistant Prostate Cancer Cell Line |
| Q99709001 | SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer |
| Q91949847 | The pathological role of Wnt5a in psoriasis and psoriatic arthritis |
| Q90092788 | Wnt5a/CaMKII/ERK/CCL2 axis is required for tumor-associated macrophages to promote colorectal cancer progression |
Search more.